FUNCTIONAL LETHALITY
Dead / Abandoned — Abandoned — failure to respond (as of 04 Oct 2021)
What this means for you
This application is over — abandoned 24 Sept 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90258907
- Mark type
- Stylized text
- Filed
- 16 Oct 2020
- Abandoned
- 24 Sept 2021
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others
Owner
- Inzen Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 04 Oct 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 04 Oct 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 23 Mar 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Mar 2021 — NON-FINAL ACTION E-MAILED
- 23 Mar 2021 — NON-FINAL ACTION WRITTEN
- 17 Mar 2021 — ASSIGNED TO EXAMINER
- 04 Dec 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Oct 2020 — NEW APPLICATION ENTERED